Core Scientific's proposed $9 billion all-stock acquisition by CoreWeave is facing opposition from major shareholders. The deal, initially valued at $20.25 per share, has seen CoreWeave's stock decline by over 30% since the announcement, reducing the offer value to just over $13 per share. This drop has led shareholders, including Core Scientific's largest investor Two Seas Capital, to argue that the deal undervalues the bitcoin mining company. Two Seas Capital has publicly declared its intention to vote against the merger unless the terms are improved, with some investors threatening a proxy fight. Shareholders are seeking better terms, such as a collar agreement, to protect against further valuation declines. The resistance from Core Scientific's shareholders raises uncertainty about the completion of the merger.